STERIS is Pleased to Announce Our Brooklyn Park, MN, USA Laboratory Now Offers GLP Cytotoxicity Testing
June 1, 2026
- Supports medical device and pharmaceutical manufacturing with additional biocompatibility testing capabilities
- Complements existing microbiological, analytical, and product and package testing services offered at Brooklyn Park, MN
As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota laboratory now offers cytotoxicity testing services in accordance with Good Laboratory Practice (GLP).
GLP cytotoxicity testing plays a critical role in evaluating the biocompatibility of medical devices and pharmaceuticals, assessing materials for potential toxicity to living cells.
Our ISO/IEC 17025 accredited cytotoxicity testing services comply with ISO 10993-5 and GLP standards, and complements the laboratory’s existing microbiological, analytical, and product and packaging testing services.
In addition to our Brooklyn Park, Minnesota location, STERIS provides laboratory testing services through a global network that includes facilities in the Americas, Europe, and Asia.
Product release to market is further supported by the STERIS AST global network of contract irradiation and gas sterilization facilities.
Go here to learn more about our comprehensive laboratory testing services.
About STERIS
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention.
WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe.
For more information, visit www.steris.com.
Related Posts
